Comorbidities in ADHD children treated with methylphenidate: a database study
<p>Abstract</p> <p>Background</p> <p>Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorder (ADHD) in children. Treatment with MPH is contraindicated in the presence of certain psychiatric, cerebro- and cardiovascular condi...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2013-01-01
|
| Series: | BMC Psychiatry |
| Online Access: | http://www.biomedcentral.com/1471-244X/13/11 |